Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Published on Apr 23, 2014in JAMA2.474
· DOI :10.1001/JAMA.2014.3312
Mark J. Kupersmith39
Estimated H-index: 39
(Mount Sinai St. Luke's and Mount Sinai Roosevelt)
Importance Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH), but there is insufficient information to establish an evidence base for its use. Objective To determine whether acetazolamide is beneficial in improving vision when added to a low-sodium weight reduction diet in patients with IIH and mild visual loss. Design, Setting, and Participants Multicenter, randomized, double-masked, placebo-controlled study of acetazolamide in 165 participants with IIH and mild visual loss who received a low-sodium weight-reduction diet. Participants were enrolled at 38 academic and private practice sites in North America from March 2010 to November 2012 and followed up for 6 months (last visit in June 2013). All participants met the modified Dandy criteria for IIH and had a perimetric mean deviation (PMD) between −2 dB and −7 dB. The mean age was 29 years and all but 4 participants were women. Interventions Low-sodium weight-reduction diet plus the maximally tolerated dosage of acetazolamide (up to 4 g/d) or matching placebo for 6 months. Main Outcomes and Measures The planned primary outcome variable was the change in PMD from baseline to month 6 in the most affected eye, as measured by Humphrey Field Analyzer. Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to −32 dB; larger negative values indicate greater vision loss. Secondary outcome variables included changes in papilledema grade, quality of life (Visual Function Questionnaire 25 [VFQ-25] and 36-Item Short Form Health Survey), headache disability, and weight at month 6. Results The mean improvement in PMD was greater with acetazolamide (1.43 dB, from −3.53 dB at baseline to −2.10 dB at month 6; n = 86) than with placebo (0.71 dB, from −3.53 dB to −2.82 dB; n = 79); the difference was 0.71 dB (95% CI, 0 to 1.43 dB; P  = .050). Mean improvements in papilledema grade (acetazolamide: −1.31, from 2.76 to 1.45; placebo: −0.61, from 2.76 to 2.15; treatment effect, −0.70; 95% CI, −0.99 to −0.41; P P  = .003) and its 10-item neuro-ophthalmic supplement (acetazolamide: 9.82, from 75.45 to 85.27; placebo: 1.59, from 75.45 to 77.04; treatment effect, 8.23; 95% CI, 3.89 to 12.56; P P Conclusions and Relevance In patients with IIH and mild visual loss, the use of acetazolamide with a low-sodium weight-reduction diet compared with diet alone resulted in modest improvement in visual field function. The clinical importance of this improvement remains to be determined. Trial Registration clinicaltrials.gov Identifier:NCT01003639
Figures & Tables
📖 Papers frequently viewed together
10 Authors (Mark J. Kupersmith)
#1Colin J. Scott (UI: University of Iowa)H-Index: 1
#2Randy H. Kardon (UI: University of Iowa)H-Index: 63
Last. Michael Wall (UI: University of Iowa)H-Index: 57
view all 5 authors...
Objectives To compare and contrast 2 methods of quantitating papilledema, namely, optical coherence tomography (OCT) and Modified Frisen Scale (MFS). Methods Digital optic disc photographs and OCT fast retinal nerve fiber layer (RNFL) thickness, fast RNFL map, total retinal thickness, and fast disc images were obtained in 36 patients with papilledema. Digital optic disc photographs were randomized and graded by 4 masked expert reviewers using the MFS. We performed Spearman rank correlations of O...
#1Ivan J. SuñerH-Index: 18
#2Gregg T. Kokame (UH: University of Hawaii)H-Index: 21
Last. Neil M. Bressler (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 92
view all 6 authors...
METHODS. In MARINA, 716 patients were randomized to monthly intravitreal ranibizumab (0.3 or 0.5 mg) or sham injections. In ANCHOR, 423 patients were randomized to monthly ranibizumab (0.3 or 0.5 mg) with sham photodynamic therapy (PDT) or sham ocular injections with verteporfin PDT. Patients had follow-up interviews and BCVA measurements over 24 months. Data were analyzed separately for MARINA and ANCHOR, and treatment groups were pooled within each trial. The clinically relevant difference in ...
#7Steven L. Galetta (UPenn: University of Pennsylvania)H-Index: 36
Purpose To determine whether a 10-Item Neuro-Ophthalmic Supplement increases the capacity of the 25-Item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) to capture self-reported visual dysfunction in patients with neuro-ophthalmologic disorders. Design A cross-sectional survey to examine the characteristics of a 10-Item Neuro-Ophthalmic Supplement to the 25-Item NEI-VFQ-25 in a cohort of patients with neuro-ophthalmologic disorders. Methods The 10-Item Neuro-Ophthalmic Suppleme...
#1Graeme F. Woodworth (Johns Hopkins University)H-Index: 35
#2Matthew J. McGirt (Johns Hopkins University)H-Index: 61
Last. Daniele RigamontiH-Index: 44
view all 5 authors...
Introduction: Cerebrospinal fluid (CSF) shunting effectively reverses symptoms of idiopathic intracranial hypertension (IIH). Lumboperitoneal (LP) shunts have traditionally been use
#1Geert MolenberghsH-Index: 84
#2Herbert ThijsH-Index: 23
Last. Raymond J. Carroll (A&M: Texas A&M University)H-Index: 118
view all 7 authors...
SUMMARY Using standard missing data taxonomy, due to Rubin and co-workers, and simple algebraic derivations, it is argued that some simple but commonly used methods to handle incomplete longitudinal clinical trial data, such as complete case analyses and methods based on last observation carried forward, require restrictive assumptions and stand on a weaker theoretical foundation than likelihood-based methods developed under the missing at random (MAR) framework. Given the availability of flexib...
#1Mark KosinskiH-Index: 54
#2Martha S. BaylissH-Index: 24
Last. Stewart J. TepperH-Index: 61
view all 10 authors...
Background: Migraine and other severe headaches can cause suffering and reduce functioning and productivity. Patients are the best source of information about such impact. Objective: To develop a new short form (HIT-6) for assessing the impact of headaches that has broad content coverage but is brief as well as reliable and valid enough to use in screening and monitoring patients in clinical research and practice. Methods: HIT-6 items were selected from an existing item pool of 54 items and from...
#1Christian J. Lueck (Canberra Hospital)H-Index: 22
#2Gawn G. McIlwaine (Western General Hospital)H-Index: 10
Background Idiopathic intracranial hypertension occurs throughout the world with an estimated incidence of one to three per 100,000 population per year. It occurs most commonly in obese young women but the cause is unknown. It presents a significant threat to sight and is associated with severe morbidity, in the form of headaches in most cases. Several different treatments have been proposed ranging from relatively conservative measures such as diuretic therapy to more invasive treatments such a...
#1James T Banta (OU: University of Oklahoma)H-Index: 2
#2Bradley K. Farris (OU: University of Oklahoma)H-Index: 14
Abstract Objective To determine the efficacy and safety of optic nerve sheath decompression in a large population of patients with pseudotumor cerebri with visual loss despite medical treatment and to suggest a treatment algorithm on the basis of these data. Design Retrospective, noncomparative, interventional case series. Participants One hundred fifty-eight eyes in 86 patients with pseudotumor cerebri. Intervention Optic nerve sheath decompression. Main outcome measures Visual acuity, visual f...
#1Lenworth N. Johnson (MU: University of Missouri)H-Index: 20
#2Gregory B. Krohel (Albany Medical College)H-Index: 22
Last. Glenville A March (Charles R. Drew University of Medicine and Science)H-Index: 1
view all 4 authors...
Abstract Objective To determine the weight loss associated with resolution of papilledema from idiopathic intracranial hypertension (IIH). Design A retrospective study. Participants Fifteen consecutive female patients with IIH associated with obesity were studied. Intervention Patients underwent weight loss and treatment with acetazolamide during a 24-week period. Main outcome measures The severity of papilledema was graded: absent (grade 0), mild (grade 1), moderate (grade 2), and marked (grade...
#1Carol M. Mangione (UCLA: University of California, Los Angeles)H-Index: 105
#2Paul P. LeeH-Index: 70
Last. Ron D. HaysH-Index: 153
view all 6 authors...
Objective To test the reliability and validity of the 51-item Field Test Version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) across 5 common chronic eye conditions. Design Prospective observational cohort study of persons with 1 of 5 chronic eye diseases who were scheduled for nonurgent visits in ophthalmology practices or had low vision from any cause, and a reference sample of persons without eye disease. Setting Six university-based ophthalmology practices and the Na...
Cited By255
#1Alfonso Hoyos-Martinez (Cincinnati Children's Hospital Medical Center)H-Index: 3
#2Vincent E. Horne (ARS: Agricultural Research Service)H-Index: 1
Last. Veeral Shah (Cincinnati Children's Hospital Medical Center)H-Index: 7
view all 4 authors...
BACKGROUND The pathophysiology underlying pseudotumor cerebri syndrome (PTCS) is complex and not well understood. There are clear differences between PTCS in adults and pediatrics. Few and isolated case reports have suggested that adrenal function may be involved, yet no large cohort study has examined this relationship. METHODS We conducted a retrospective single-center study of children who presented with a diagnosis of PTCS and had cortisol testing measured between January 2010 and September ...
#1Nevio Cimolai (UBC: University of British Columbia)H-Index: 20
Acetazolamide was developed nearly 70 years ago and continues to be used for niche indications. Mechanisms of action are relatively less well-studied than clinical applications. Several potential uses span the spectrum of neurological illnesses, but yet neurological side effects complicate short- and long-term applications for many patients. This review examines the basic science and clinical usages of acetazolamide germane to neurological and psychiatric spectrums. The existing publications wer...
#1Gülten Öztürk (Marmara University)
#2Dilsad Turkdogan (Marmara University)H-Index: 12
Last. Adnan Dagcinar (Marmara University)H-Index: 14
view all 6 authors...
Diagnosis and treatment of pseudotumor cerebri syndrome in children is still a challenge for clinicians. The aim of this study is to reveal the influence of presentation age and CSF opening pressure on long-term prognosis of pseudotumor cerebri and share our clinical data of the very young age (≤ 5-year) group. This retrospective study includes the patients followed by the Marmara University Pediatric Neurology Clinic between years 2012 and 2020 diagnosed with definite, probable, or suggestive p...
#1Brianna N Brun (Nationwide Children's Hospital)
#2Shawn C. Aylward (Nationwide Children's Hospital)H-Index: 7
Abstract null null Primary intracranial hypertension (PIH) is characterized by clinical signs of increased intracranial pressure, papilledema, elevated opening pressure, and absence of mass lesion, hydrocephalus, or meningeal enhancement on neuroimaging. Visual changes are a common presenting feature and if untreated there is risk of irreversible vision loss. There have been recent proposed changes to the criteria for PIH along with studies looking at the differences in imaging characteristics b...
#1Sophia Knodel (Saarland University)H-Index: 2
#2S.N. Roemer (Saarland University)
Last. S. Kalampokini (UCY: University of Cyprus)
view all 11 authors...
BACKGROUND To assess the validity of neurosonological parameters (transorbital sonography (TOS)) for detection and monitoring of patients with idiopathic intracranial hypertension (IIH). METHODS Prospective, single-center, case-controlled study in 25 patients with IIH and 19 controls. Visual parameters of papilledema, visual acuity, computerized static threshold perimetry, fundus examination, and neurosonological parameters of papilledema/optic disc elevation (ODE), optic nerve sheath diameter (...
BACKGROUND Idiopathic intracranial hypertension (IIH) is a disease which is difficult to diagnose and moreover difficult to treat. We developed a strategy for long-term telemonitoring of intracranial pressure (ICP), by incorporation of the NEUROVENT®-P-tel System, with the goal of improved diagnosis and consequent therapy of this disease. We highlight the results obtained through this approach. METHODS Twenty patients with suspected IIH who were treated in our hospital from August 2014 to Octobe...
#1Aku Kaipainen (University of Eastern Finland)H-Index: 1
#2Erik Martoma (University of Eastern Finland)
Last. Ville Leinonen (University of Eastern Finland)H-Index: 28
view all 15 authors...
BACKGROUND Idiopathic intracranial hypertension (IIH) is a rare disease of unknown aetiology related possibly to disturbed cerebrospinal fluid (CSF) dynamics and characterised by elevated intracranial pressure (ICP) causing optic nerve atrophy if not timely treated. We studied CSF dynamics of the IIH patients based on the available literature and our well-defined cohort. METHOD A literature review was performed from PubMed between 1980 and 2020 in compliance with the PRISMA guideline. Our study ...
#1Amirmohsen Arbabi (Wills Eye Institute)
#2Xuan Bao (PKU: Peking University)
Last. Reza Razeghinejad (Wills Eye Institute)H-Index: 4
view all 4 authors...
Glaucoma is a progressive loss of retinal ganglion cells leading to visual field loss. Lowering intraocular pressure is currently the only modifiable risk factor to slow glaucoma progression. Intraocular pressure-lowering options include topical and systemic medications, lasers, and surgical procedures. Glaucoma eye drops play a major role in treating this blinding disease. Similar to all medications, the glaucoma medications have their own adverse effects. The majority of glaucoma medications w...
Last. Betül Baykan (Istanbul University)H-Index: 31
view all 3 authors...
Abstract null null Background and objective null Idiopathic intracranial hypertension (IIH) is an increase of intracranial pressure without a known cause, which usually presented with headache. This study aimed to evaluate the changing diagnosis and management approaches of neurologists for IIH in light of recent data. null null null Methods null An online questionnaire about IIH was developed covering 28 questions, and five sections: demographic data, diagnosis, examination, treatment, and foll...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.